Validation of the GERAADA Score for Predicting 30‐Day Mortality Rate in Acute Type A Aortic Dissection: A Single‐Center Study in China
Open Access
- 2 September 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (17) , e040838
Abstract
Background: This study aimed to validate the predictive performance of the GERAADA (German Registry for Acute Type A Aortic Dissection) score in predicting 30‐day mortality rate in patients with acute type A aortic dissection in China. Methods: We retrospectively analyzed 526 patients who underwent surgical treatment for acute type A aortic dissection at our institution between 2018 and 2021. The predictive performance of the GERAADA score was evaluated using calibration (observed‐to‐expected ratio and Hosmer–Lemeshow test) and discrimination (area under the receiver operating characteristic curve). Logistic regression analysis was performed to identify risk factors of 30‐day mortality rate. Stratified analyses were conducted to assess performance across different risk categories. Results: The cohort exhibited distinct characteristics, including younger age, longer intervals from onset to admission, and more extensive aortic arch procedures. The GERAADA score demonstrated good calibration (Hosmer–Lemeshow test, P =0.461) and discriminative power (area under the receiver operating characteristic curve=0.863). Low‐risk patients (score <20; 78.7% of cohort) had a mortality rate of 2.4%, while high‐risk patients (score ≥20) showed mortality rates aligning with predicted values (observed‐to‐expected ratio=1.2). Patients with preoperative critical conditions or end‐organ malperfusion exhibited a significantly higher mortality rate. Furthermore, we identified independent risk factors beyond the GERAADA scoring system, and these factors exhibited significant differences between high‐ and low‐risk patients. To address these findings, we developed a mortality risk assessment strategy based on GERAADA score, which further stratifies patients according to their specific clinical characteristics, serving as an optimization and expansion of the GERAADA score. Conclusions: This study validated the GERAADA score in China for predicting mortality risk in patients with acute type A aortic dissection, showing strong performance in discrimination and calibration. We also developed a mortality risk assessment strategy based on the GERAADA score, offering a practical framework for clinical use. The modular design allows for easy adaptation across centers, although further multicenter studies are needed to confirm its generalizability.Keywords
This publication has 21 references indexed in Scilit:
- External validation of the ARCH score in patients undergoing aortic arch reconstruction under circulatory arrestThe Journal of Thoracic and Cardiovascular Surgery, 2024
- Current Surgical Management of Acute Type A Aortic Dissection in ChinaJACC: Asia, 2022
- 2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissectionThe Journal of Thoracic and Cardiovascular Surgery, 2021
- About usefulness of GERAADA scoreEuropean Journal of Cardio-Thoracic Surgery, 2021
- Evaluation of the GERAADA score for prediction of 30-day mortality in patients with acute type A aortic dissectionEuropean Journal of Cardio-Thoracic Surgery, 2020
- Prediction of mortality rate in acute type A dissection: the German Registry for Acute Type A Aortic Dissection scoreEuropean Journal of Cardio-Thoracic Surgery, 2020
- Outcome of open total arch replacement in the modern eraJournal of Vascular Surgery, 2016
- The Impact of Pre-Operative Malperfusion on Outcome in Acute Type A Aortic DissectionJACC, 2015
- Risk Factors for Hospital Death in Patients With Acute Aortic DissectionHeart, Lung and Circulation, 2015
- Aortic root conservative repair of acute type A aortic dissection involving the aortic root: Fate of the aortic root and aortic valve functionThe Journal of Thoracic and Cardiovascular Surgery, 2013